Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank11
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-36.95M
↓ 80% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-20.54M
Historical baseline
PeriodValueYoY Change
TTM$-36.95M+0.3%
2024$-37.07M-13.4%
2023$-32.69M-47.4%
2022$-22.18M+7.4%
2021$-23.94M-4.6%
2020$-22.89M+6.9%
2019$-24.59M-206.6%
2018$-8.02M-523.8%
2013$1.89M+77.7%
2012$1.07M-